Revised forecast
Fiscal year ending March 2027 · Six months and full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
In the near term, depreciation and amortization and research and development expenses are expected to weigh on profit because of upfront investment in the development of high-value-added products and products for advanced fields, expansion of production capacity, and the launch of new businesses. For the fiscal year ended March 2026, net sales increased due to higher orders, while operating profit decreased because of higher raw material prices and research and development investment. Ordinary profit increased due to factors including royalties received for technology and foreign exchange gains, while net income attributable to owners of the parent decreased because of impairment losses and other factors.
Impairment losses of ¥252.118 million, loss on disposal of property, plant and equipment of ¥160.352 million, loss on sale of property, plant and equipment of ¥44.510 million, and valuation loss on investment securities of ¥357 thousand. Total extraordinary losses: ¥457.338 million.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → Cumulative second quarter: ¥23,000 million; full year: ¥44,000 million（Cumulative second quarter: 20.0% (year on year); full year: 14.8% (year on year)） |
| Operating profit | Not disclosed → Cumulative second quarter: ¥500 million; full year: ¥300 million（Cumulative second quarter: 5.1% (year on year); full year: -2.1% (year on year)） |
| Ordinary income | Not disclosed → Cumulative second quarter: ¥500 million; full year: ¥300 million（Cumulative second quarter: -16.2% (year on year); full year: -58.8% (year on year)） |
| Profit attributable to owners of the parent | Not disclosed → Cumulative second quarter: ¥400 million; full year: ¥230 million（Cumulative second quarter: -3.4% (year on year); full year: 228.0% (year on year)） |
| Net income per share | Not disclosed → Cumulative second quarter: ¥35.72; full year: ¥20.54 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Six months and full year |
| Previous-period results | Fiscal year ended March 2026: net sales of ¥38,323 million, operating profit of ¥306 million, ordinary profit of ¥728 million, net income attributable to owners of the parent of ¥70 million, and net income per share of ¥6.26 |
| Reason for the revision | In the near term, depreciation and amortization and research and development expenses are expected to weigh on profit because of upfront investment in the development of high-value-added products and products for advanced fields, expansion of production capacity, and the launch of new businesses. For the fiscal year ended March 2026, net sales increased due to higher orders, while operating profit decreased because of higher raw material prices and research and development investment. Ordinary profit increased due to factors including royalties received for technology and foreign exchange gains, while net income attributable to owners of the parent decreased because of impairment losses and other factors. |
| Details and amount of extraordinary loss | Impairment losses of ¥252.118 million, loss on disposal of property, plant and equipment of ¥160.352 million, loss on sale of property, plant and equipment of ¥44.510 million, and valuation loss on investment securities of ¥357 thousand. Total extraordinary losses: ¥457.338 million. |
| Dividend forecast revision | For the fiscal year ending March 2027, an annual dividend of ¥54 is planned, comprising an interim dividend of ¥25 and a year-end dividend of ¥29. No information is provided on whether the dividend forecast was revised. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended March 2026, net sales increased due to higher orders for components for mobile information terminals and consumer equipment, as well as thermal printheads. Operating profit decreased because of higher raw material prices, including precious metals, and research and development investment in advanced fields. Ordinary profit increased due to factors including royalties received for technology and foreign exchange gains, while net income attributable to owners of the parent decreased mainly because an impairment loss of ¥252 million was recorded. For the fiscal year ending March 2027, depreciation and amortization and research and development expenses are expected to weigh on profit because of upfront investment in technology development, production capacity expansion and the launch of new businesses.